Get started
Liquidia CorporationLiquidia CorporationLiquidia Corporation

Liquidia Corporation

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

LQDA trade ideas

Buy Signal - 40% profit targetBuying this on the dip - my price target is ~9/share which will give me ~40% profit. This has been on my list for about a week, just looking for an entry point. If you're able to get in anywhere in the two demand zones (green boxes on the chart - especially at the 5.25 level), I'd say go for it - I am. Earnings coming up, so be cautious. About the company: Liquidia Technologies, Inc. is a late-stage clinical biopharmaceutical company. It focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients. The company's product candidate consists of LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain which are in clinical stage. Liquidia Technologies, Inc. is based in NC, United States.
NASDAQ:LQDALong
by dzygadlo
LQDA Technical Analysis 🧙Liquidia Corp, formerly Liquidia Technologies Inc is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Liquidia is developing two product candidates from its own pipeline: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
NASDAQ:LQDALong
by unfair_advantage
2
LQDA Technical Analysis 🧙Liquidia Corp, formerly Liquidia Technologies Inc is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Liquidia is developing two product candidates from its own pipeline: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. If you understand the idea,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
NASDAQ:LQDALong
by unfair_advantage
2
LQDA Technical Analysis.Liquidia Corp, formerly Liquidia Technologies Inc is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Liquidia is developing two product candidates from its own pipeline: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. If you understand the idea,🎯 press a thumb up! 👍👍👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
NASDAQ:LQDALong
by unfair_advantage
Easy 10%er upcoming Consolidation at LQDA in range of their all time low after FDA issued the biotech company a CRL due to COVID restrictions. After speaking with regulators at the FDA, The company expressed this CRL had nothing to do with the underlying data. Options activity has been healthy. I believe price will increase from here, which is why I have started a position and continue to add on any meaningful dips (eg yesterday, the company issued PR for $200 mln mixed securities shelf offering) causing week hands to sell. Stop loss under previous low, friends. let’s go!! Disclaimer: this is not recommendation to buy or sell, this information is to be used for educational purposes only. Trade at your own risk.
NASDAQ:LQDALong
by follow_the_money
Long LQDA on heavy insider buyingSo while US exchanges were closed and celebrated Independence Day, so we had some time to analyze the markets and find something interesting. LQDA may be one of those interesting stocks. Before I continue, I'm obliged to disclose the fact that I do not hold LQDA stocks and only consider buying. Please note that this analysis is my point of view, and trading is a risky activity. You are the only responsible for your trading actions. Now, with disclaimers being said, let's take a look at the trade. Ok, so what is LQDA? LQDA is a biotechnological company that does something they call "PRINT" technology. I won't argue I completely understand what it means even after I read a number of articles, so I better work with numbers. Here are some of the strong arguments in favor of buying. First of all, on July 2nd the company announced the closing of its underwritten stocks at $8.00. Of course, the news tanked the stock price from $10.5 to $8 and below. A good thing is that one of the key insiders, Eshelman Ventures, bought additional stocks worth 15 million dollars. Such strong trading activity of an insider usually indicates a good background and good long-term perspectives. Moreover, Eshelman Ventures is the fund that specializes in Biotechnological companies. I didn't analyze their portfolio yet, but I read about the founder, Fred Eshelman, and I believe their purchase has a strong reasoning. Besides heavy insiders buying, we see that the stock price is close to both - lower uptrend channel (please note log scale I'm using) and near the support level. The levels combination and high volume during the last days after the gap also suggest possible uptrend continuation. Finally, LQDA is a final stage biotechnological companies with sales at about 8 million dollars. Given strong insider support, we may conclude that this is the stock that may combine private equity returns with lower risk (given the support of key shareholders). So, the stock looks interesting and I consider going long if the price rebounds from the support level or trendline and closes above $8.00
NASDAQ:LQDALong
by Mikrg
LQDA accumulation 300% upside(STOCKS)before we kick start the update. your upvotes/subs are appreciated. Why get subbed to to me on Tradingview? -15+ years real live trading experience -TOP Author on TradingView -professional chart break downs -key levels -no junk on my charts -frequent updates -covering FX/crypto/US stocks -24/7 uptime so constant updates So without further due. Keep it short/simple and to the point. LQDA accumulation 300% upside(STOCKS) Strong ongoing accumulation in progress 4d LQDA. recommend buying near range lows. TP bulls is +300%. this is BUY/HOLD setup, won't work for daytraders. might take 12-24 weeks until TP, so this is for patient traders only. good luck traders! get subbed to stay tuned for all the latest updates. also add likes to support my efforts, thank you.
NASDAQ:LQDALong
by ProjectSyndicate
3
LQDALONG Risk Disclaimer : Trading foreign exchange on margin carries a high level of risk, and may not be suitable for all investors. Before deciding to trade foreign exchange, you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or all of your initial investment and therefore you should not invest money that you cannot afford to lose. You must do your own due diligence for each trading signal and only invest according to your personal risk tolerance.
NASDAQ:LQDALong
by FHtrading